| # | Title | Journal | Year | Citations |
|---|
| 1 | Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women | New England Journal of Medicine | 2015 | 1,094 |
| 2 | Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization | Nature | 2022 | 928 |
| 3 | Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis | Lancet, The | 2018 | 452 |
| 4 | Integration of Antiretroviral Therapy with Tuberculosis Treatment | New England Journal of Medicine | 2011 | 451 |
| 5 | Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? | Nature Medicine | 2009 | 390 |
| 6 | Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants | Journal of Virology | 2009 | 354 |
| 7 | Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa | Journal of Virology | 2006 | 334 |
| 8 | Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) | Lancet, The | 2018 | 269 |
| 9 | Defeating AIDS—advancing global health | Lancet, The | 2015 | 234 |
| 10 | Achieving the health Millennium Development Goals for South Africa: challenges and priorities | Lancet, The | 2009 | 214 |
| 11 | Symptomatic Vaginal Discharge Is a Poor Predictor of Sexually Transmitted Infections and Genital Tract Inflammation in High-Risk Women in South Africa | Journal of Infectious Diseases | 2012 | 171 |
| 12 | Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa | BMC Pediatrics | 2007 | 159 |
| 13 | SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape | Cell Host and Microbe | 2022 | 153 |
| 14 | Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection | Nature Communications | 2022 | 145 |
| 15 | The Development of CD4 Binding Site Antibodies during HIV-1 Infection | Journal of Virology | 2012 | 123 |
| 16 | Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa | International Journal of Epidemiology | 2011 | 109 |
| 17 | Evaluating community engagement in global health research: the need for metrics | BMC Medical Ethics | 2015 | 108 |
| 18 | Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization | Nature | 0 | 104 |
| 19 | Preventing HIV Infection in Women: A Global Health Imperative | Clinical Infectious Diseases | 2010 | 97 |
| 20 | Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis | PLoS Medicine | 2018 | 96 |
| 21 | Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge | Science Translational Medicine | 2017 | 87 |
| 22 | Acceptability of HIV Self-Testing in Sub-Saharan Africa: Scoping Study | AIDS and Behavior | 2018 | 86 |
| 23 | Do human rights matter to health? | Lancet, The | 2007 | 79 |
| 24 | Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa | International Journal of Tuberculosis and Lung Disease | 2015 | 77 |
| 25 | Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial | Lancet, The | 2016 | 70 |
| 26 | Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them | New England Journal of Medicine | 2021 | 66 |
| 27 | Omicron infection enhances Delta antibody immunity in vaccinated persons | Nature | 2022 | 66 |
| 28 | Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa | New England Journal of Medicine | 2022 | 65 |
| 29 | HIV testing and disclosure: a qualitative analysis of TB patients in South Africa | AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV | 2007 | 64 |
| 30 | Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV | International Journal of Tuberculosis and Lung Disease | 2016 | 62 |
| 31 | Preferential adherence to antiretroviral therapy over tuberculosis treatment: A qualitative study of drug-resistant TB/HIV co-infected patients in South Africa | Global Public Health | 2014 | 61 |
| 32 | Multidrug-Resistant Tuberculous Meningitis in Children in Durban, South Africa | Pediatric Infectious Disease Journal | 2006 | 60 |
| 33 | Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype CgagVaccine in Healthy HIV-1-Uninfected Adults | Vaccine Journal | 2012 | 60 |
| 34 | Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa | International Journal of Tuberculosis and Lung Disease | 2012 | 54 |
| 35 | Interventions to modify sexual risk behaviours for preventing HIV in homeless youth | The Cochrane Library | 2011 | 53 |
| 36 | Acceptability of HIV self-testing among men and women in KwaZulu-Natal, South Africa | AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV | 2019 | 50 |
| 37 | Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review | Journal of Infectious Diseases | 2021 | 50 |
| 38 | Determinants of Vaginal Microbiota Composition | Frontiers in Cellular and Infection Microbiology | 2020 | 48 |
| 39 | “Bitten By Shyness”: Menstrual Hygiene Management, Sanitation, and the Quest for Privacy in South Africa | Medical Anthropology: Cross Cultural Studies in Health and Illness | 2016 | 47 |
| 40 | Transmission of drug-resistant tuberculosis in HIV-endemic settings | Lancet Infectious Diseases, The | 2019 | 47 |
| 41 | Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region | PLoS ONE | 2013 | 46 |
| 42 | Relationship between female genital tract infections, mucosal interleukin‐17 production and local T helper type 17 cells | Immunology | 2015 | 45 |
| 43 | Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework | Lancet HIV,the | 2020 | 44 |
| 44 | Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study | Lancet HIV,the | 2015 | 43 |
| 45 | Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study | New England Journal of Medicine | 2021 | 42 |
| 46 | High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa | PLoS ONE | 2016 | 40 |
| 47 | A Qualitative Study of Patient Motivation to Adhere to Combination Antiretroviral Therapy in South Africa | AIDS Patient Care and STDs | 2015 | 39 |
| 48 | Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study | The Lancet Global Health | 2022 | 38 |
| 49 | Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa | Clinical Infectious Diseases | 2021 | 36 |
| 50 | Determinants of Optimal Adherence Over Time to Antiretroviral Therapy Amongst HIV Positive Adults in South Africa: A Longitudinal Study | AIDS and Behavior | 2011 | 35 |
